Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies

Christopher D. Demaula, Kyle R. Bonneau, Nigel J Maclachlan

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Six neutralizing monoclonal antibodies (Mabs) and nine neutralization resistant viral variants (escape-mutant viruses (EMVs)) were used to further characterize the neutralization determinants of bluetongue virus serotype 10 (BTV10). The EMVs were produced by sequential passage of a highly cell culture adapted United States prototype strain of BTV10 in the presence of individual neutralizing Mabs. Mabs were characterized by neutralization and immune precipitation assays, and phenotypic properties of EMVs were characterized by neutralization assay. Sequencing of the gene segments encoding outer capsid proteins VP2 and VP5 identified mutations responsible for the altered phenotypic properties exhibited by individual EMVs. Amino acid substitutions in VP2 were responsible for neutralization resistance in most EMVs, whereas an amino acid substitution in VP5, without any change in VP2, was responsible for the neutralization resistance of one EMV. The data confirm that VP2 contains the major neutralization determinants of BTV, and that VP5 also can influence neutralization of the virus. The considerable plasticity of the neutralization determinants of BTV has significant implications for future development of non-replicating vaccines. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalVirus Research
Volume67
Issue number1
DOIs
StatePublished - Mar 2000

Fingerprint

Bluetongue virus
Capsid Proteins
Monoclonal Antibodies
Viruses
Amino Acid Substitution
Neutralizing Antibodies
Serogroup
Immunoprecipitation
Vaccines
Cell Culture Techniques
Mutation

Keywords

  • Bluetongue virus
  • L2 gene
  • M5 gene
  • Neutralization epitope

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Virology

Cite this

Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies. / Demaula, Christopher D.; Bonneau, Kyle R.; Maclachlan, Nigel J.

In: Virus Research, Vol. 67, No. 1, 03.2000, p. 59-66.

Research output: Contribution to journalArticle

@article{b60e1d8d6c2f447393dbf38ccd627a57,
title = "Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies",
abstract = "Six neutralizing monoclonal antibodies (Mabs) and nine neutralization resistant viral variants (escape-mutant viruses (EMVs)) were used to further characterize the neutralization determinants of bluetongue virus serotype 10 (BTV10). The EMVs were produced by sequential passage of a highly cell culture adapted United States prototype strain of BTV10 in the presence of individual neutralizing Mabs. Mabs were characterized by neutralization and immune precipitation assays, and phenotypic properties of EMVs were characterized by neutralization assay. Sequencing of the gene segments encoding outer capsid proteins VP2 and VP5 identified mutations responsible for the altered phenotypic properties exhibited by individual EMVs. Amino acid substitutions in VP2 were responsible for neutralization resistance in most EMVs, whereas an amino acid substitution in VP5, without any change in VP2, was responsible for the neutralization resistance of one EMV. The data confirm that VP2 contains the major neutralization determinants of BTV, and that VP5 also can influence neutralization of the virus. The considerable plasticity of the neutralization determinants of BTV has significant implications for future development of non-replicating vaccines. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Bluetongue virus, L2 gene, M5 gene, Neutralization epitope",
author = "Demaula, {Christopher D.} and Bonneau, {Kyle R.} and Maclachlan, {Nigel J}",
year = "2000",
month = "3",
doi = "10.1016/S0168-1702(00)00130-1",
language = "English (US)",
volume = "67",
pages = "59--66",
journal = "Virus Research",
issn = "0168-1702",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies

AU - Demaula, Christopher D.

AU - Bonneau, Kyle R.

AU - Maclachlan, Nigel J

PY - 2000/3

Y1 - 2000/3

N2 - Six neutralizing monoclonal antibodies (Mabs) and nine neutralization resistant viral variants (escape-mutant viruses (EMVs)) were used to further characterize the neutralization determinants of bluetongue virus serotype 10 (BTV10). The EMVs were produced by sequential passage of a highly cell culture adapted United States prototype strain of BTV10 in the presence of individual neutralizing Mabs. Mabs were characterized by neutralization and immune precipitation assays, and phenotypic properties of EMVs were characterized by neutralization assay. Sequencing of the gene segments encoding outer capsid proteins VP2 and VP5 identified mutations responsible for the altered phenotypic properties exhibited by individual EMVs. Amino acid substitutions in VP2 were responsible for neutralization resistance in most EMVs, whereas an amino acid substitution in VP5, without any change in VP2, was responsible for the neutralization resistance of one EMV. The data confirm that VP2 contains the major neutralization determinants of BTV, and that VP5 also can influence neutralization of the virus. The considerable plasticity of the neutralization determinants of BTV has significant implications for future development of non-replicating vaccines. Copyright (C) 2000 Elsevier Science B.V.

AB - Six neutralizing monoclonal antibodies (Mabs) and nine neutralization resistant viral variants (escape-mutant viruses (EMVs)) were used to further characterize the neutralization determinants of bluetongue virus serotype 10 (BTV10). The EMVs were produced by sequential passage of a highly cell culture adapted United States prototype strain of BTV10 in the presence of individual neutralizing Mabs. Mabs were characterized by neutralization and immune precipitation assays, and phenotypic properties of EMVs were characterized by neutralization assay. Sequencing of the gene segments encoding outer capsid proteins VP2 and VP5 identified mutations responsible for the altered phenotypic properties exhibited by individual EMVs. Amino acid substitutions in VP2 were responsible for neutralization resistance in most EMVs, whereas an amino acid substitution in VP5, without any change in VP2, was responsible for the neutralization resistance of one EMV. The data confirm that VP2 contains the major neutralization determinants of BTV, and that VP5 also can influence neutralization of the virus. The considerable plasticity of the neutralization determinants of BTV has significant implications for future development of non-replicating vaccines. Copyright (C) 2000 Elsevier Science B.V.

KW - Bluetongue virus

KW - L2 gene

KW - M5 gene

KW - Neutralization epitope

UR - http://www.scopus.com/inward/record.url?scp=0034076662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034076662&partnerID=8YFLogxK

U2 - 10.1016/S0168-1702(00)00130-1

DO - 10.1016/S0168-1702(00)00130-1

M3 - Article

C2 - 10773319

AN - SCOPUS:0034076662

VL - 67

SP - 59

EP - 66

JO - Virus Research

JF - Virus Research

SN - 0168-1702

IS - 1

ER -